Latest News

TSS (TSSI) drew fresh attention after CEO Darryll E. Dewan and CFO Daniel M. Chism presented at the 28th Annual Needham Growth Conference, giving institutional investors direct access to management and the company’s current positioning. See our latest analysis for TSS. The conference appearance comes at a time when momentum in TSS’s share price has picked up, with a 7 day share price return of 41.27% and a 30 day share price return of 59.60% following a weaker 90 day share price return of...

Perdoceo Education (PRDO) has completed a US$74.8 million share repurchase tranche and announced a new buyback authorization of up to US$100 million, drawing fresh attention to how its stock is being valued. See our latest analysis for Perdoceo Education. The buyback announcements come after a period of mixed share price momentum, with a 7.67% 1 month share price return and an 11.57% 3 month share price decline. Yet longer term total shareholder returns of 16.29% over 1 year and more than 2x...

Flight Centre Travel Group (ASX:FLT) has been actively buying back its own shares on market, cancelling stock and reducing the overall share count. This capital move appears to be drawing fresh investor attention. See our latest analysis for Flight Centre Travel Group. That buy-back activity has come alongside a solid run in the share price, with Flight Centre’s 90 day share price return of 29.14% and 1 day move of 3.36% suggesting momentum has picked up recently. However, the 1 year total...

Earlier in January 2026, Amylyx Pharmaceuticals announced it had selected AMX0318, a long-acting GLP-1 receptor antagonist discovered with Gubra A/S, as a development candidate for post-bariatric hypoglycemia and other rare diseases following extensive preclinical evaluation. The move expands Amylyx’s pipeline into GLP-1 biology and rare metabolic conditions, while triggering up to US$50 million in potential milestones and mid-single digit royalties to Gubra, including US$4 million tied to...

Nexteer Automotive Group has announced that Hervé Paul Gino Boyer resigned as executive director, senior vice president and global chief operating officer on January 19, 2026, with the company stating he has no disagreement with the Board and only an unresolved annual incentive payment to be settled. His departure comes shortly after Nexteer highlighted its role in advancing China’s new Steer-by-Wire standard, underscoring a leadership transition amid ongoing investment in Motion-by-Wire...

NOVONIX Limited recently updated its timeline for mass production of battery-grade synthetic graphite anode material for Panasonic Energy, now expecting production to begin in the second half of 2027 while still planning to start industrial-grade graphite mass production for other customers in 2026. This timing shift highlights how stringent qualification protocols and customer-specific requirements can shape the build-out of a North American synthetic graphite supply chain. Next, we will...

Datwyler recently announced a collaboration with LTS Device Technologies and Stevanato Group to create a pre-verified large-volume subcutaneous drug delivery ecosystem, showcased at Pharmapack in Paris in January 2026. The partnership highlights how Stevanato’s EZ-fill large-volume cartridges can be integrated with advanced plungers and wearable devices to support at-home administration of sensitive therapies. We’ll now explore how this large-volume self-administration platform could...

In recent weeks, controlling shareholder Zvi Levy sold a 6.9% stake in Israeli defense manufacturer Aryt Industries to a mix of Israeli and foreign investors, including institutions such as Phoenix and Mor, ahead of the January 15 Tel Aviv Stock Exchange index weighting update. This transaction not only broadens Aryt’s investor base and is expected to enhance trading liquidity, but also follows shareholder pressure that led the company to drop plans to list its Reshef Technologies...

AnaptysBio, Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, where President and CEO Daniel R. Faga outlined the company’s latest corporate and pipeline updates. This appearance comes as AnaptysBio reports very large year-over-year improvements in both earnings per share and revenue, alongside higher analyst earnings forecasts that are reshaping investor expectations. We’ll now examine how this combination of very large profitability gains and a...

StarHub recently opened its first compact, high-velocity concept store at Suntec City, offering fast consultations, tailored plan recommendations, and efficient service setups for customers on the move. This new format deepens StarHub’s physical presence in a major business hub, reinforcing its broader push toward more personalized, omnichannel customer support. We’ll now examine how this compact, high-velocity Suntec City store format could influence StarHub’s broader investment narrative...

LightPath Technologies recently presented at the 28th Annual Needham Growth Conference held at The Lotte New York Palace Hotel in New York, drawing interest from investors and industry observers. This conference appearance matters because investors often watch these sessions for updates on product focus, contract pipelines, and management’s execution priorities. We’ll now examine how LightPath’s Needham Growth Conference presentation might influence its investment narrative, particularly...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

EHang Holdings Limited has appointed founding team member Shuai Feng as Chief Technology Officer, effective January 14, 2026, formalizing his leadership across pilotless human-carrying eVTOL development, supply chain, and compliance functions. By combining deep product engineering experience with responsibility for procurement, manufacturing scale-up, and safety-focused compliance, Feng’s expanded remit tightly links EHang’s technology roadmap with its commercialization and industrial...

Why CBIZ (CBZ) is on investors’ radar CBIZ (CBZ) has drawn attention after a period of softer share performance, including a 40% decline over the past year. This has prompted investors to reassess the stock against its fundamentals and current valuation. See our latest analysis for CBIZ. CBIZ’s 1 day share price return of 1.4% decline and 7 day share price return of 7.23% decline sit against a 1 year total shareholder return of 39.89% decline. This suggests momentum has faded after earlier...

Without a single clear news event driving it today, Via Transportation (VIA) has still drawn attention after a sharp share price decline over the past month and the past 3 months, prompting closer scrutiny from investors. See our latest analysis for Via Transportation. At a latest share price of $22.90, Via Transportation’s recent slide includes a 7 day share price return of 10.34%, extending to a 30 day share price return of 31.23% and a 90 day share price return of 52.05%, which suggests...

Massimo Group ( NASDAQ:MAMO ) shares have retraced a considerable 27% in the last month, reversing a fair amount of...

Ohmyhome Limited ( NASDAQ:OMH ) shares have had a really impressive month, gaining 95% after a shaky period beforehand...

Key Insights Portland General Electric's estimated fair value is US$53.94 based on Dividend Discount Model Portland...

Despite an already strong run, Fluence Energy, Inc. ( NASDAQ:FLNC ) shares have been powering on, with a gain of 36% in...

Unfortunately for some shareholders, the Jin Medical International Ltd. ( NASDAQ:ZJYL ) share price has dived 27% in...

Even if it's not a huge purchase, we think it was good to see that Peter Blume-Jensen, the Co-Founder of Acrivon...

Klaviyo, Inc. ( NYSE:KVYO ) shareholders won't be pleased to see that the share price has had a very rough month...

Antero Midstream Corporation ( NYSE:AM ) has announced that it will pay a dividend of $0.225 per share on the 11th of...

AutoNation, Inc. recently announced that it will release its fourth-quarter 2025 financial results, for the period ended December 31, 2025, on February 6, 2026, before the market opens, followed by a management conference call and webcast available via its investor relations website. In parallel, JPMorgan upgraded AutoNation while the company moved to acquire Jerry’s Toyota in Baltimore and expanded its share repurchase authorization by US$1.00 billion to about US$1.28 billion, highlighting...